Keyphrases
Primary Prevention
100%
Low Risk
100%
Risk of Death
100%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
100%
Late Gadolinium Enhancement
100%
Implantable Defibrillator
66%
Cardioverter-defibrillator Implantation
50%
Confidence Interval
33%
Hazard Ratio
33%
Patients with Heart Failure
33%
High Risk
16%
Cardiovascular Mortality
16%
Group Events
16%
High-risk Population
16%
Multivariable
16%
Low-risk Group
16%
Left Ventricular Ejection Fraction
16%
Event Rate
16%
Mortality Prediction
16%
Risk Stratification
16%
New York Heart Association Functional Class
16%
Device Implantation
16%
Late Gadolinium Enhancement Magnetic Resonance Imaging
16%
Ischemic Cardiomyopathy
16%
Dilated Cardiomyopathy
16%
Implantable Cardioverter-defibrillator Shock
16%
Inappropriate Shock
16%
Antitachycardia Pacing
16%
Intermediate-risk Group
16%
Medicine and Dentistry
Amino Terminal Sequence
100%
Primary Prevention
100%
Brain Natriuretic Peptide
100%
Implantable Automatic Defibrillator
100%
Gadolinium
100%
Hazard Ratio
28%
Congestive Heart Failure
28%
Shock (Circulatory)
14%
Magnetic Resonance Imaging
14%
Cardiovascular System
14%
New York Heart Association Class
14%
High Risk Population
14%
Low Risk Population
14%
Heart Left Ventricle Ejection Fraction
14%
Risk Stratification
14%
Ischemic Cardiomyopathy
14%
Dilated Cardiomyopathy
14%
Defibrillator
14%
Intermediate Risk Population
14%
Antitachycardia Pacing
14%